MYLAN ApS: Financial statements 2018
CVR: 28107013
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
MYLAN ApS (CVR 28107013) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 2,815 and a net result of DKK 1,408 compared with DKK 1,702 the year before. That is an increase of 27% compared with the year before. Equity in the 2018 report amounted to DKK 187,723. The solvency ratio was 52.7%.
- Gross Profit
- DKK 2,815
- Profit/Loss
- DKK 1,408
- Equity
- DKK 187,723
- Total Assets
- DKK 356,022
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 3 t. | 1 t. | 188 t. | 0 |
| 2017 | - | 2 t. | 2 t. | 186 t. | 0 |
| 2016 | - | 3 t. | 2 t. | 185 t. | - |
| 2015 | - | - | 0 | 0 | - |
| 2014 | - | - | 0 | 0 | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of November 5, 2018, Jose Javier Cotarelo has joined the board of directors of MYLAN ApS.
As of November 5, 2018, Anthonius Matthijs van 't Hullenaar has left the board of directors of MYLAN ApS.
MYLAN ApS has published its annual report for 2017. Gross profit came to DKK 2,217, and the net result was DKK 1,702.
As of June 1, 2018, Kurt Glud has joined the board of directors of MYLAN ApS.
As of June 1, 2018, Gitte Jürgens has left the board of directors of MYLAN ApS.
About MYLAN ApS
MYLAN ApS was a Danish company of the type Anpartsselskab based in Ballerup, founded in 2004. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MERCK NM ApS and NM PHARMA ApS. In 2024, the company reported a gross profit of DKK 3,631 and a net result of DKK 3,137 compared with DKK 1,952 the year before. Equity in the 2024 report amounted to DKK 198,978.